International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

CTI Announces New Promotions 02/13/2020
Post-Pandemic Paradigm Shifts and New Dimensions of Value, a… 08/14/2020
Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018 07/28/2020
ICER Releases Final Report for Type 2 Diabetes Add-on Therapies 12/10/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Patient Drug Costs Increased as Health Plans Promote… 08/07/2020